0007

PKU HealthCare Corp.,Ltd. (000788)

Market Closed
20 Dec, 06:57
XSHE XSHE
¥
6. 80
-0.17
-2.44%
¥
3.64B Market Cap
- P/E Ratio
0.2% Div Yield
43,290,033 Volume
- Eps
¥ 6.97
Previous Close
Day Range
6.75 6.95
Year Range
4.04 7.38
Want to track 000788 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

000788 Chart

PKU HealthCare Corp.,Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
- CEO
XSHE Exchange
CNE0000008M0 ISIN
China Country
797 Employees
- Last Dividend
18 Mar 2011 Last Split
- IPO Date

Overview

PKU HealthCare Corp.,Ltd. is a prominent figure in the pharmaceutical sector within China, focusing on the research, development, manufacturing, and marketing of a wide range of pharmaceutical products. The company, which finds its origins in 1965, was initially known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd., before rebranding to its current name in November 2013. With its headquarters located in Chongqing, China, PKU HealthCare Corp.,Ltd. stands as a testament to decades of innovation and dedication to healthcare advancements in various therapeutic categories.

Products and Services

The array of pharmaceutical products offered by PKU HealthCare Corp.,Ltd. spans multiple therapeutic areas, each addressing specific health concerns and contributing to the overall well-being of patients. These categories include:

  • Anti-tumor: Focuses on the development and sale of drugs used for the treatment of various cancers, aiming to improve patient survival rates and quality of life.
  • Psychoneurological: Offers medications for the treatment of psychological and neurological disorders, supporting brain health and cognitive functions.
  • Cardiovascular: Develops drugs to treat conditions affecting the heart and blood vessels, contributing to the reduction of heart disease risks.
  • Immunosuppressive: Provides solutions for managing the immune system, especially for patients undergoing organ transplants or dealing with autoimmune diseases.
  • Antimicrobial: Produces drugs to combat infections caused by bacteria, viruses, and other pathogens, safeguarding patient health against infectious diseases.
  • Antipyretic and analgesic: Offers products to relieve fever and pain, aiding in comfort and recovery during illness.
  • Digestive system: Focuses on medications that aid in the treatment of gastrointestinal disorders, enhancing digestive health.
  • Regulate immunity: Develops products to help modulate the immune system, offering potential benefits for those with varied immune-related conditions.
  • Oncology: Specializes in the research and treatment of cancer, providing hope and new options for patients battling this disease.
  • Anti-allergic: Offers treatments for allergic reactions, aiming to reduce symptoms and improve patient comfort.
  • Blood sugar regulation: Produces medications that help manage diabetes by regulating blood sugar levels, promoting overall health and preventing complications.
  • Mental disorder: Focuses on drugs for the treatment and management of mental health disorders, supporting emotional and psychological well-being.
  • Blood volume expansion: Offers solutions for conditions requiring the expansion of blood volume, critical in managing certain medical emergencies and surgeries.

Contact Information

Address: Liangjiangtiandi
Phone: 86 23 6301 4398